- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 586.6M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $597.8M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $597.7M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $757.9M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $930.7M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $3.14B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.05B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $10.13B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $10B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.39B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.51B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.83B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.99B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $6.21B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $6.29B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $13.02B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $13.06B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 604.1M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $200K |
| Capex | Q1 2025 · Mar 31, 2024 | $65.3M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$53.5M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.58 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.58 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $428.4M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $256.7M |
| Net Income | Q1 2025 · Mar 31, 2024 | $351.9M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $349M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $1.04B |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $286.9M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $1.33B |